Other assets impairments, restructuring and other items (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Other Assets Impairments, Restructuring and Other Items

	Three months ended
	March 31,
	2021		2020
	(U.S. $ in millions)
Impairments of long-lived tangible assets (1)	$	48	$	75
Contingent consideration		3		6
Restructuring		81		39
Other		4		—
Total	$	137	$	121

(1) Including impairments related to exit and disposal activities

Summary of Restructuring Plan Including Costs Related to Exit and Disposal

The following tables provide the components of costs associated with Teva’s restructuring plan, including other costs associated with Teva’s restructuring plan and recorded under different items: 

	Three months ended March 31,
	2021		2020
	(U.S. $ in millions)
Restructuring
Employee termination	$	79	$	33
Other		2		6
Total	$	81	$	39

Summary of Restructuring Accruals

The following table provides the components of and changes in the Company’s restructuring accruals:

	Employee termination costs			Other			Total
	(U.S. $ in millions )
Balance as of January 1, 2021	$	(115	)	$	(7	)	$	(122	)
Provision		(79	)		(2	)		(81	)
Utilization and other*		33			2			35
Balance as of March 31, 2021	$	(161	)	$	(7	)	$	(168	)

	Employee termination costs			Other			Total
	(U.S. $ in millions )
Balance as of January 1, 2020	$	(208	)	$	(7	)	$	(215	)
Provision		(33	)		(6	)		(39	)
Utilization and other*		69			6			75
Balance as of March 31, 2020	$	(172	)	$	(7	)	$	(179	)

* Includes adjustments for foreign currency translation.